MedPath

Using Ultrasound to detect diaphragm dysfunction in patients with acute deterioration of chronic obstructive lung disease and assessing its utility in estimating failure of Non invasive ventilation in such patients

Not yet recruiting
Conditions
Chronic obstructive pulmonary disease with (acute) exacerbation,
Registration Number
CTRI/2020/05/025462
Brief Summary

Acute exacerbation of chronic obstructive pulmonary disease (AECOPD) is defined as an acute event characterized by a worsening of the patient’s respiratory symptoms. Noninvasive (NIV) is the first-line management in AECOPD. Diaphragmatic dysfunction (DD) is a common reason for dyspnoea in COPD. Ultrasound is a cheap, safe, non-invasive, less time consuming, bedside tool for detecting DD. Among various USG  parameters, change in the diaphragmatic thickness (ΔTDI) has been found to be the most sensitive parameter of DD. The aim of our study will be to assess the utility of ultrasound assessed DD (continuous and new-onset) in estimating the NIV failure of patients with AECOPD.

Detailed Description

Not available

Recruitment & Eligibility

Status
Not Yet Recruiting
Sex
All
Target Recruitment
60
Inclusion Criteria

Patients with Acute exacerbation of chronic obstructive lung disease with acidosis (PaCO2 >45mm Hg, pH <7.25) in need of non-invasive ventilation.

Exclusion Criteria
  • Patients with acute pulmonary edema.
  • History of interstitial lung disease.
  • History of neuromuscular disease.
  • Chest wall deformities.
  • Previously diagnosed diaphragmatic palsy.
  • Hemodynamic instability (Systolic blood pressure <90 mm Hg).
  • Intracranial hypertension.
  • Any contraindication to Non-invasive ventilation, 10.
  • Need for immediate endotracheal intubation or invasive mechanical ventilation at ICU admission.

Study & Design

Study Type
Observational
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Non-invasive ventilation (NIV) failure rate with respect to new onset or continuous diaphragmatic dysfunction assessed by ultrasound guided measurement of change in diaphragmatic thickness (ΔTDI).ΔTDI assessed at 2 hrs on NIV or immediately prior to intubation if patient requires intubation before 2 hrs of NIV. | NIV failure assessed during ICU stay
Secondary Outcome Measures
NameTimeMethod
Diaphragmatic dysfunction assessed by ultrasound guided measurement of change in diaphragmatic thickness (ΔTDI).At ICU admission
Time to NIV failure.ICU admission (Day 1) to time point of intubation.
Ventilation days (Non - invasive).Duration of non-invasive ventilation
Ventilation days (invasive).Duration of invasive ventilation
Length of stay in ICU.ICU admission ( Day 1) to patients ICU discharge or death or 30 days whichever is earlier
In hospital length of stay.ICU admission (Day 1) to patient discharge or death or 30 days whichever is earlier.
ICU mortality, In hospital mortality and 30 day mortality.ICU admission (Day 1) to 30 days follow up or death whichever is earlier.

Trial Locations

Locations (1)

Critical Care Unit

🇮🇳

Dehradun, UTTARANCHAL, India

Critical Care Unit
🇮🇳Dehradun, UTTARANCHAL, India
Nupur B Patel
Principal investigator
8489926988
nupurbpatel@yahoo.co.in

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.